Effect of caffeine on acetaminophen hepatotoxicity in cultured hepatocytes treated with ethanol and isopentanol

Toxicology and Applied Pharmacology

Volumn 185, Issue 2, 2002, Pages 91-97

  DiPetrillo, Keith ^b   Wood, Sheryl ^a   Kostrubsky, Vsevolod ^c   Chatfield, Kathryn ^b   Bement, Jenna ^a   Wrighton, Steven ^d   Jeffery, Elizabeth ^e   Sinclair, Peter ^a,b   Sinclair, Jacqueline ^a,b  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c PFIZER INC   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CAFFEINE; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; DEXAMETHASONE; ISOPENTYL ALCOHOL; MESSENGER RNA; PARACETAMOL; TROLEANDOMYCIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HYDROXYLATION; LIVER CELL CULTURE; LIVER PROTECTION; LIVER TOXICITY; NONHUMAN; PROTEIN EXPRESSION; RAT; RISK FACTOR;

ANIMALIA; RODENTIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0036943138     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2002.9535     Document Type: Article

References (41)

1. de Waziers, I., Bouguet, J., Beaune, P. H., Gonzalez, F. J., Ketterer, B., and Barouki, R. (1992). Effects of ethanol, dexamethasone and RU 486 on expression of cytochromes P450 2B, 2E, 3A and glutathione transferase pi in a rat hepatoma cell line (Fao). Pharmacogenetics 2, 12-18.
2. Floren, C. H., Thesleff, P., and Nilsson, A. (1987). Severe liver damage caused by therapeutic doses of acetaminophen. Acta Med. Scand. 222, 285-288.
3. Genter, M. B., Liang, H. C., Gu, J., Ding, X., Negishi, M., McKinnon, R. A., and Nebert, D. W. (1998). Role of CYP2A5 and 2G1 in acetaminophen metabolism and toxicity in the olfactory mucosa of the Cyp1a2(-/-) mouse. Biochem. Pharmacol. 55, 1819-1826.
4. Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W., and Gilman, A. G. (1996). The Pharmacological Basis of Therapeutics. McGraw-Hill, New York.
5. Harvison, P. J., Guengerich, F. P., Rashed, M. S., and Nelson, S. D. (1988). Cytochrome P-450 isozyme selectivity in the oxidation of acetaminophen. Chem. Res. Toxicol. 1, 47-52.
6. Hoshino, U., and Kawasaki, H. (1995). Urinary 6β-hydroycortisol excretion in patients with alcoholic liver disease. Res. Commun. Alcoholic Subst. Abuse 16, 116-124. http://www.cspinet.org/new/cafchart.htm.
7. Jaw, S., and Jeffery, E. H. (1993). Interaction of caffeine with acetaminophen: Correlation of the effect of caffeine on acetaminophen hepatotoxicity and acetaminophen bioactivation following treatment of mice with various cy-tochrome P450 inducing agents. Biochem. Pharmacol. 46, 493-501.
8. Kalhorn, T. F., Lee, C. A., Slattery, J. T., and Nelson, S. D. (1989). Effect of methylxanthines on acetaminophen hepatotoxicity in various induction states. J. Pharmacol. Exp. Ther. 262, 112-116.
9. Kostrubsky, V. E., Strom, S. C., Wood, S. G., Wrighton, S. A., Sinclair, P. R., and Sinclair, J. F. (1995a). Ethanol and isopentanol increase CYP3A and CYP2E in primary cultures of human hepatocytes. Arch. Biochem. Biophys. 322, 516-520.
10. Kostrubsky, V. E., Wood, S. G., Bush, M. D., Szakacs, J., Bement, W. J., Sinclair, P. R., Jeffery, E. H., and Sinclair, J. F. (1995b). Acute hepatotoxicity of acetaminophen in rats treated with ethanol plus isopentanol. Biochem. Pharmacol. 50, 1743-1748.
11. Kostrubsky, V., Szakacs, J., Jeffery, E., Wood, S., Bement, W., Wrighton, S., Sinclair, P., and Sinclair, J. (1997a). Role of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicity. Toxicol. Appl. Pharmacol. 143, 516-520.
12. Kostrubsky, V. E., Lewis, L. D., Wood, S. G., Sinclair, P. R., Wrighton, S. A., and Sinclair, J. F. (1997b). Effect of taxol on cytochrome P450 3A and acetaminophen toxicity in cultured rat hepatocytes: Comparison to dexamethasone. Toxicol. Appl. Pharmacol. 142, 79-86.
13. Kostrubsky, V. E., Ramachandran, V., Venkataramanan, R., Dorko, K., Esplen, J. E., Zhang, S., Sinclair, J. F., Wrighton, S. A., and Strom, S. C. (1999). The use of human hepatocyte cultures to study the induction of cytochrome P-450. Drug Metab. Dispos. 27, 887-894.
14. Lee, C. A., Lillibridge, J. H., Nelson, S. D., and Slattery, J. T. (1996). Effects of caffeine and theophylline on acetaminophen pharmacokinetics: P450 inhibition and activation. J. Pharmacol. Exp. Ther. 277, 287-291.
15. Lee, C. A., Thummel, K. E., Kalhorn, T. F., Nelson, S. D., and Slattery, J. T. (1991). Inhibition and activation of acetaminophen reactive metabolite formation by caffeine: Roles of cytochromes P-4501A1 and IIIA2. Drug Metab. Dispos. 19, 348-353.
16. Lesser, P. B., Vietti, M. M., and Clark, W. D. (1986). Lethal enhancement of therapeutic doses of acetaminophen by alcohol. Dig. Dis. Sci. 31, 103-105.
17. Lindenthal, J., Sinclair, J. F., Howell, S., Cargill, I., Sinclair, P. R., and Taylor, T. (1993). Toxicity of paracetamol in cultured chick hepatocytes treated with methotrexate. Eur. J. Pharmacol. 228, 289-298.
18. Louis, C. A., Sinclair, J. F., Wood, S. G., Lambrecht, L. K., Sinclair, P. R., and Smith, E. L. (1993). Synergistic induction of cytochrome P450 by ethanol and isopentanol in cultures of chick embryo and rat hepatocytes. Toxicol. Appl. Pharmacol. 118, 169-176.
19. Louis, C. A., Wood, S. G., Kostrubsky, V., Sinclair, P. R., and Sinclair, J. F. (1994). Synergistic increases in rat hepatic cytochrome P450s by ethanol and isopentanol. J. Pharmacol. Exp. Ther. 269, 838-845.
20. Lowry, O., Rosenbrough, N., Farr, A., and Randall, R. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
21. Miners, J. O., Drew, R., and Birkett, D. J. (1984). Mechanism of action of paracetamol protective agents in mice in vivo. Biochem. Pharmacol. 33, 2995-3000.
22. Nelson, S. (1990). Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin. Liver Dis. 10, 267-278.
23. Newton, D. J., Wang, R. W., and Lu, A. Y. (1995). Cytochrome P450 inhibitors: Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab. Dispos. 23, 154-158.
24. Niemela, O., Parkkila, S., Pasanen, M., Iimur, Y., Bradford, B., and Thurman, R. G. (1998). Early alcoholic liver injury: Formation of protein adducts with acetaldehyde and lipid peroxidation products, and expression of CYP2E1 and CYP3A. Alcohol Clin. Exp. Res. 22, 2118-2124.
25. Niemela, O., Parkkila, S., Juvonen, R. O., Vitala, K., Gelboin, H. V., and Pasanen, M. (2000). Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases. J. Hepatol. 33, 893-901.
26. Patten, C., Thomas, P., Guy, R., Lee, M., Gonzalez, F., Guengerich, P., and Yang, C. (1993). Cytochrome P450 enzymes involved in acetaminophen activation by rat and liver human microsomes and their kinetics. Chem. Res. Toxicol. 6, 511-518.
27. Ribereau-Gayon, J., and Peynaud, E. (1970). Biological Occurrence and Significance of Alcohols in Natural Products. Pergamon, London.
28. Roberts, B. J., Shoaf, S. E., and Song, B. J. (1995). Rapid changes in cytochrome P4502E1 (CYP2E1) activity and other P450 isozymes following ethanol withdrawal in rats. Biochem. Pharmacol. 49, 1665-1673.
29. Schuetz, E. G., Li, D., Omiecinski, C. J., Muller-Eberhard, U., Kleinman, H. K., Elswick, B., and Guzelian, P. S. (1988). Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. J. Cell. Physiol. 134, 309-323.
30. Seeff, L. B., Cuccherini, B. A., Zimmerman, H. J., Adler, E., and Benjamin, S. B. (1986). Acetaminophen hepatotoxicity in alcoholics: A therapeutic misadventure. Ann. Intern. Med. 104, 399-404.
31. Sinclair, J. F., Wood, S. G., Smith, E. L., Sinclair, P. R., and Koop, D. R. (1989). Comparison of the form(s) of cytochrome P-450 induced by ethanol and glutethimide in cultured chick hepatocytes. Biochem. Pharmacol. 38, 657-664.
32. Sinclair, J. F., Smith, L., Bement, W. J., Sinclair, P. R., and Bonkowsky, H. L. (1982). Increases in cytochrome p-450 in cultured hepatocytes mediated by 3- and 4-carbon alcohols. Biochem. Pharmacol. 31, 2811-2815.
33. Sinclair, J. F., McCaffrey, J., Sinclair, P. R., Bement, W. J., Lambrecht, L. K., Wood, S. G., Smith, E. L., Schenkman, J. B., Guzelian, P. S., Park, S. S., et al. (1991). Ethanol increases cytochromes P450IIE, IIB1/2, and IIIA in cultured rat hepatocytes. Arch. Biochem. Biophys. 284, 360-365.
34. Sinclair, J., Szakacs, J., Wood, S., Kostrubsky, V., Jeffery, E., Wrighton, S., Wright, D., and Sinclair, P. (2000). Acetaminophen hepatotoxicity increased by short-term treatment with ethanol and isopentanol: Protection by triacetyloleandomycin. Biochem. Pharmacol. 59, 445-454.
35. Spielberg, S. P. (1985). Acetaminophen toxicity in lymphocytes heterozygous for glutathione synthetase deficiency. Can. J. Physiol. Pharmacol. 63, 468-471.
36. Tang, W., and Stearns, R. A. (2001). Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions. Curr. Drug Metab. 2, 185-198.
37. Thummel, K. E., Lee, C. A., Kunze, K. L., Nelson, S. D., and Slattery, J. T. (1993). Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem. Pharmacol. 45, 1563-1569.
38. Whitcomb, D. C., and Block, G. D. (1994). Association of acetaminophen hepatotoxicity with fasting and ethanol use [see comments]. JAMA 272, 1845-1850.
39. Wrighton, S. A., Schuetz, E. G., Thummel, K. E., Shen, D. D., Korzekwa, K. R., and Watkins, P. B. (2000). The human CYP3A subfamily: Practical considerations. Drug Metab. Rev. 32, 339-361.
40. Zerilli, A., Ratanasavanh, D., Lucas, D., Goasduff, T., Dreano, Y., Menard, C., Picart, D., and Berthou, F. (1997). Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1. Chem. Res. Toxicol. 10, 1205-1212.
41. Zimmerman, H. J., and Maddrey, W. C. (1995). Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure. Hepatology 22, 767-773.